Please Enter a Search Term

News Releases

SUBJECT: Minister Efford Announces Over $2.1 Million For Newfoundland and Labrador Health Research Projects
DATE: March 5, 2004

Projects include studies of psoriatic arthritis and deafness

ST. JOHN’S (March 5, 2004) – T he Honourable John Efford, Minister of Natural Resources, on behalf of the Honourable Pierre Pettigrew, Minister of Health, announced today along with Dr. Alan Bernstein, President of the Canadian Institutes of Health Research (CIHR), an investment of over $2.1 million to fund health research in Newfoundland . Minister Efford made the announcement at Memorial University along with the Honourable Carolyn Bennett, Minister of State (Public Health).

"We want a Canada that is a world leader in developing and applying the path-breaking health technologies of the 21st century, creating high-quality jobs to keep our bright young people in Canada , and benefiting all Canadians with discoveries that advance better health and health care," said Minister Efford. “The projects we are announcing in Newfoundland and Labrador today represent the Government’s commitment to creating that Canada .”

“Health research is the foundation of the health care system,” said Minister Bennett. “Through new discoveries, treatments and interventions, and better understanding about how best to organize, finance and deliver health services and health policies, research strengthens the health care system, improves the quality of life and health of all Canadians and reduces the economic burden of illness on the economy.”

The five research projects funded will be conducted at Memorial University . The studies will be carried out over periods of one to five years and cover a wide spectrum of health research. The Minister highlighted two researchers whose work exemplifies CIHR's comprehensive, problem-based approach to funding health research. They are:

  • Dr. Proton Rahman , who is examining the role of the CARD15 gene in psoriatic arthritis; and
  • Dr. Terry Lynn Young, who is studying the genetic basis of deafness in Newfoundland .

“Today’s announcement is an example of CIHR’s commitment to investing in high-quality people and outstanding, innovative science,” said Dr. Bernstein. “I believe health research is central to Canada ’s future, as it sits squarely at the crossroads of personal health, public health, innovation and economic growth.”

Memorial President Axel Meisen said, "This latest round of CIHR funding for Memorial strengthens our research capabilities, particularly in areas related to genetics. Without CIHR's help, this research could not be done. The benefits of the research will be immense for Newfoundlanders and Labradorians, as well as patients elsewhere. I am delighted with CIHR's continued support of Memorial University .”

The funding highlighted today is part of a larger package recently announced by the Minister of Health, the Honourable Pierre Pettigrew .

The Canadian Institutes of Health Research is the Government of Canada ’s premier agency for health research. Its objective is to excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system. www.cihr-irsc.gc.ca

- 30 -

Attachments :

Grant Allocations

Highlighted projects backgrounder

FURTHER INFORMATION:

Janet Weichel, CIHR, Communications, (613) 941-4563
Tom Hornsby, Office of the Honourable John Efford, (709) 690-7544
Suzanne Cowan, Office of the Honourable Carolyn Bennett, (709) 299-7051
Sharon Gray , Memorial University , (709) 777-8397

Ce document est également disponible en français .